Mark W. Johnson

11.8k total citations · 1 hit paper
286 papers, 7.1k citations indexed

About

Mark W. Johnson is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Mark W. Johnson has authored 286 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Ophthalmology, 82 papers in Radiology, Nuclear Medicine and Imaging and 34 papers in Neurology. Recurrent topics in Mark W. Johnson's work include Retinal and Macular Surgery (54 papers), Retinal Diseases and Treatments (51 papers) and Glaucoma and retinal disorders (43 papers). Mark W. Johnson is often cited by papers focused on Retinal and Macular Surgery (54 papers), Retinal Diseases and Treatments (51 papers) and Glaucoma and retinal disorders (43 papers). Mark W. Johnson collaborates with scholars based in United States, United Kingdom and Canada. Mark W. Johnson's co-authors include Victor M. Elner, Andrew K. Vine, J. Donald M. Gass, Nieraj Jain, Todd E. Schneiderman, Barbara A. Blodi, Lee M. Jampol, Mark S. Scher, Susan M. Ludington‐Hoe and Karl R. Olsen and has published in prestigious journals such as Nature, Physical Review Letters and Nature Communications.

In The Last Decade

Mark W. Johnson

274 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go

2024 38 citations Mark W. Johnson et al. American Journal of Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark W. Johnson United States	50	4.0k	2.7k	856	745	711	286	7.1k
Szu‐Yuan Wu Taiwan	44	2.6k 0.7×	2.0k 0.7×	214 0.3×	1.3k 1.8×	1.3k 1.9×	385	8.3k
José S. Pulido United States	52	5.3k 1.3×	2.6k 1.0×	1.7k 2.0×	2.6k 3.5×	828 1.2×	339	10.6k
Philip I. Murray United Kingdom	54	3.6k 0.9×	709 0.3×	527 0.6×	2.0k 2.6×	1.2k 1.6×	262	9.4k
David Huang United States	26	4.7k 1.2×	4.9k 1.8×	207 0.2×	1.2k 1.7×	362 0.5×	79	13.2k
Gary C. Brown United States	58	7.7k 1.9×	4.6k 1.7×	1.2k 1.4×	819 1.1×	1.8k 2.5×	323	10.6k
Robert E. Anderson United States	42	406 0.1×	1.3k 0.5×	936 1.1×	1.2k 1.7×	954 1.3×	349	7.3k
John Carson Allen Singapore	40	328 0.1×	1.2k 0.4×	232 0.3×	463 0.6×	694 1.0×	346	6.4k
Daniel J. Wallace United States	63	201 0.1×	4.6k 1.7×	796 0.9×	1.1k 1.4×	866 1.2×	292	16.3k
Feng Gao United States	62	452 0.1×	1.3k 0.5×	504 0.6×	2.9k 3.9×	1.4k 1.9×	473	13.4k
Maurício Castillo United States	55	434 0.1×	3.6k 1.3×	2.7k 3.2×	952 1.3×	1.8k 2.5×	491	13.0k

Countries citing papers authored by Mark W. Johnson

Since Specialization

Citations

This map shows the geographic impact of Mark W. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Johnson more than expected).

Fields of papers citing papers by Mark W. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Johnson. The network helps show where Mark W. Johnson may publish in the future.

Co-authorship network of co-authors of Mark W. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Johnson. A scholar is included among the top collaborators of Mark W. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Johnson. Mark W. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Hyeohn, et al.. (2025). Filomicelle‐Embedded Composite Hydrogels for Localized Gelation Within the Anterior Chamber of the Eye. Small. 22(7). e08236–e08236. 1 indexed citations

Rezende, Flávio, Emmanouil Rampakakis, David Steel, et al.. (2023). Surgical classification for large macular hole: based on different surgical techniques results: the CLOSE study group. International Journal of Retina and Vitreous. 9(1). 4–4. 32 indexed citations

Fujimoto, Satoko, Gregg T. Kokame, Edwin H. Ryan, et al.. (2023). Macular Retinoschisis from Optic Disc without a Visible Optic Pit or Advanced Glaucomatous Cupping (No Optic Pit Retinoschisis [NOPIR]). Ophthalmology Retina. 7(9). 811–818. 4 indexed citations

Johnson, Mark W., et al.. (2021). Corona Prevention and Control- A Preview. 4(1). 8–22. 1 indexed citations

Johnson, Mark W., et al.. (2020). Limited Vitrectomy versus Observation for Bilateral Terson Syndrome in a Child. Ophthalmology Retina. 5(3). 312–314. 2 indexed citations

Johnson, Mark W. & Thomas J. Wubben. (2019). Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions. Investigative Ophthalmology & Visual Science. 60(9). 1733–1733. 2 indexed citations

Bathke, C.G., et al.. (2015). 1 AN ASSESSMENT OF THE PROLIFERATION RESISTANCE OF MATERIALS IN ADVANCED NUCLEAR FUEL CYCLES. 2 indexed citations

Chinskey, Nicholas D. & Mark W. Johnson. (2014). Acute Macular Neuroretinopathy Following Trauma. Investigative Ophthalmology & Visual Science. 55(13). 5940–5940.

Sleaford, B., Brian A. Collins, B.B. Ebbinghaus, et al.. (2010). NUCLEAR MATERIAL ATTRACTIVENESS: AN ASSESSMENT OF MATERIAL FROM PHWR'S IN A CLOSED THORIUM FUEL CYCLE. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations

10.

Conrad, Paul, David N. Zacks, & Mark W. Johnson. (2008). Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration. SHILAP Revista de lepidopterología. 4 indexed citations

11.

Hammel, Joy, Robin Jones, Janet L. Smith, et al.. (2008). Environmental barriers and supports to the health, function, and participation of people with developmental and intellectual disabilities: Report from the State of the Science in Aging with Developmental Disabilities Conference. Disability and health journal. 1(3). 143–149. 32 indexed citations

12.

Johnson, Mark W., et al.. (2007). Bilateral Proliferative Retinopathy in Chronic Myelogenous Leukemia. Retina. 27(1). 124–125. 18 indexed citations

13.

Abecasis, Gonçalo R., Beverly M. Yashar, Yu Zhao, et al.. (2004). Age-Related Macular Degeneration: A High-Resolution Genome Scan for Susceptibility Loci in a Population Enriched for Late-Stage Disease. The American Journal of Human Genetics. 74(3). 482–494. 116 indexed citations

14.

Anderson, Robert M., David C. Musch, Robin Nwankwo, et al.. (2003). Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial.. PubMed. 13(1). 40–6. 47 indexed citations

15.

Anderson, Robert M., David C. Musch, Robin Nwankwo, et al.. (2003). For the patient. Eye screening can prevent eye disease. Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial.. PubMed. 13(1). 149–149. 6 indexed citations

16.

Grazul‐Bilska, Anna T., Lawrence P. Reynolds, Jan Bilski, et al.. (2002). Effects of basic fibroblast growth factor (FGF-2) on proliferation of human skin fibroblasts in type II diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes. 110(4). 176–181. 37 indexed citations

17.

Johnson, Mark W., et al.. (2001). Technique of Right Laparoscopic Donor Nephrectomy: A Single Center Experience. American Journal of Transplantation. 1(3). 293–295. 15 indexed citations

18.

Johnson, Mark W., et al.. (1996). Selective use of veno‐venous bypass in orthotopic liver transplantation. Clinical Transplantation. 10(2). 181–185. 24 indexed citations

19.

Johnson, Mark W. & Andrew K. Vine. (1987). Hydroxychloroquine Therapy in Massive Total Doses Without Retinal Toxicity. American Journal of Ophthalmology. 104(2). 139–144. 65 indexed citations

20.

Chiswick, M L, et al.. (1983). Protective effect of vitamin E (DL-alpha-tocopherol) against intraventricular haemorrhage in premature babies.. BMJ. 287(6385). 81–84. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact